Navigation Links
Recognizing blood poisoning quickly
Date:12/9/2011

Is the patient suffering from blood poisoning? To answer this question, the doctor draws a blood sample and sends it to a central laboratory for testing. This takes up valuable time, which could cost the patient his life. In future, physicians will be able to analyze blood there and then and have the results within twenty minutes. This is made possible by a biochip, developed by scientists at the Fraunhofer Institute for Physical Measurement Techniques IPM in Freiburg. "To analyze the biochip we have also designed a fully automatic device to carry out all the examination steps," explains Dr. Albrecht Brandenburg, group manager at the IPM. "All the doctor has to do is place the sample in the apparatus and wait for the results."

Meanwhile, within the device there's plenty going on: it starts by preparing the blood sample. Red blood cells are separated from the blood and the plasma that remains is guided onto the biochip. When patients are suffering from sepsis, their immune system reacts by producing certain proteins. The biochip uses these in its diagnosis: there are antibodies positioned on the chip which fit these proteins like a key fits a lock. If the proteins are present in the blood, the antibodies fish them out of the fluid and bind them to the chip. But how does the apparatus know if proteins have been caught? "The chip is rinsed with a solution containing the appropriate antibodies, which have in turn been marked with a fluorescent dye," explains IPM scientist Dr. Manuel Kemmler. "These bind to the proteins meaning antibodies, protein and marked antibodies are all firmly linked to each other and to the chip's surface. When the chip is illuminated, the dye lights up." The apparatus sees lots of little illuminated dots that show the protein was in the blood. If the patient is healthy, however, the chip remains dark.

The researchers can even test for different proteins at the same time in one cycle. This is done by placing various different catcher molecules on the chip, to which specific molecules in the blood attach themselves. A cunning selection of proven protein markers allows the scientists to obtain additional important information about the severity and cause of the illness.

Together with colleagues from a university hospital, the researchers have already successfully tested prototypes of the device and biochip. Each biochip can only be used once so they have to be affordable. "We predict that in the long run, with production on a large enough scale, each chip will cost no more than one euro," says Brandenburg. There are various possible applications: other conditions such as heart attacks or cancers can also be investigated this way. What's more, the chip facilitates doping and urine testing as well as the quality assessment of foodstuffs.


'/>"/>
Contact: Dr. Albrecht Brandenburg
albrecht.brandenburg@ipm.fraunhofer.de
49-761-885-7306
Fraunhofer-Gesellschaft
Source:Eurekalert  

Related biology news :

1. MIT: Why we have difficulty recognizing faces in photo negatives
2. Psychologists find skill in recognizing faces peaks after age 30
3. Recognizing gibbons from their regional accents
4. Scientist plans to test for blood pressure genes affected by age
5. Discovery of natural compounds that could slow blood vessel growth
6. New blood test for Down syndrome
7. On the trail of a targeted therapy for blood cancers
8. Lower your blood pressure, hydrate your skin and reduce dental plaque -- with chocolate?
9. Building the blood-brain barrier
10. Apelin hormone injections powerfully lower blood sugar
11. Battling bacteria in the blood: Researchers tackle deadly infections
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recognizing blood poisoning quickly
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... NEW YORK , Jan. 24, 2017 /PRNewswire/ ... market study of the laboratory use of nuclear ... of 363 experienced end-users and profiled current practices, ... three years, as well as growth and opportunities. ... NMR, Instrument suppliers, NMR instruments, needs and innovation ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ... 2017 , ... David Nolte, PhD accepted Purdue University’s 2016 ... Research Park of West Lafayette, Indiana. , The top commercialization award is ... success with, commercializing discoveries from Purdue research. “This award is truly an honor. ...
(Date:2/23/2017)... Aviva Systems Biology Corporation (ASB) which ... GenWay Biotech Incorporated, a protein solutions and applications ... for both the research and diagnostic markets. ... capabilities for both entities. GenWay,s 18 years of experience ... complement ASB,s objective to become a leading provider ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... announced that is has acquired Kendall Research Systems, LLC (KRS) clinical ... (MIT) that develops neural interface technology for research and clinical applications. The terms ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... medical education provider of women’s health, primary care, and specialty education, announced ... Continuing Medical Education (ACCME). ACCME’s Accreditation with Commendation is a six-year accreditation ...
Breaking Biology Technology: